APA način citiranja

Cartron, G., Hourcade-Potelleret, F., Morschhauser, F., Salles, G., Wenger, M., Truppel-Hartmann, A., & Carlile, D. J. (2016). Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma. Haematologica.

Čikaški stil citiranja

Cartron, Guillaume, Florence Hourcade-Potelleret, Franck Morschhauser, Gilles Salles, Michael Wenger, Anna Truppel-Hartmann, i David J. Carlile. "Rationale for Optimal Obinutuzumab/GA101 Dosing Regimen in B-cell Non-Hodgkin Lymphoma." Haematologica 2016.

MLA način citiranja

Cartron, Guillaume, et al. "Rationale for Optimal Obinutuzumab/GA101 Dosing Regimen in B-cell Non-Hodgkin Lymphoma." Haematologica 2016.